BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33256657)

  • 1. The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice.
    Kaliszewski K; Diakowska D; Nowak Ł; Wojtczak B; Rudnicki J
    BMC Cancer; 2020 Nov; 20(1):1166. PubMed ID: 33256657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
    Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Updated AJCC/TNM Staging System for Papillary Thyroid Cancer (8th Edition): From the Perspective of Genomic Analysis.
    Kim K; Kim JH; Park IS; Rho YS; Kwon GH; Lee DJ
    World J Surg; 2018 Nov; 42(11):3624-3631. PubMed ID: 29750323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is a simplified TNM staging system more clinically relevant than the American Joint Committee on Cancer system for the follicular variant of papillary thyroid cancer?
    Hu D; Huang Y; Zeng W; Chen S; Huang Y; Li M; Long W; Huang J; Wei W; Zhang C; Liu Z; Guo L
    Ann Transl Med; 2020 Apr; 8(7):463. PubMed ID: 32395507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Analysis of The American Joint Committee on Cancer 8th Edition T Staging System for Papillary Thyroid Carcinoma.
    Tran B; Roshan D; Abraham E; Wang L; Garibotto N; Wykes J; Campbell P; Ebrahimi A
    J Clin Endocrinol Metab; 2018 Jun; 103(6):2199-2206. PubMed ID: 29672723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of T and N Categories of the American Joint Commission on Cancer, 8th Edition, With Metastasis and Survival in Patients With Orbital Sarcoma.
    Sa HS; Rubin ML; Ning J; Li W; Tetzlaff MT; McGovern SL; Paulino AC; Herzog CE; Gill JB; Esmaeli B
    JAMA Ophthalmol; 2020 Apr; 138(4):374-381. PubMed ID: 32105303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.
    Gąsior-Perczak D; Pałyga I; Szymonek M; Kowalik A; Walczyk A; Kopczyński J; Lizis-Kolus K; Trybek T; Mikina E; Szyska-Skrobot D; Gadawska-Juszczyk K; Hurej S; Szczodry A; Słuszniak A; Słuszniak J; Mężyk R; Góźdź S; Kowalska A
    PLoS One; 2018; 13(10):e0204668. PubMed ID: 30273371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using The Cancer Genome Atlas data to refine the 8th edition of the American Joint Committee on Cancer staging for papillary thyroid carcinoma.
    Poma AM; Macerola E; Torregrossa L; Elisei R; Santini F; Basolo F
    Endocrine; 2021 Apr; 72(1):140-146. PubMed ID: 32915437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions.
    Tam S; Boonsripitayanon M; Amit M; Fellman BM; Li Y; Busaidy NL; Cabanillas ME; Dadu R; Sherman S; Waguespack SG; Williams MD; Goepfert RP; Gross ND; Perrier ND; Sturgis EM; Zafereo ME
    Thyroid; 2018 Oct; 28(10):1301-1310. PubMed ID: 30141373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refining the eighth edition AJCC TNM classification and prognostic groups for papillary thyroid cancer with lateral nodal metastasis.
    Kim HI; Kim K; Park SY; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Ahn HS; Kim SW; Kim TH; Chung JH
    Oral Oncol; 2018 Mar; 78():80-86. PubMed ID: 29496063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of radioactive iodine treatment on survival among papillary thyroid cancer patients according to the 7th and 8th editions of the AJCC/TNM staging system: a SEER-based study.
    Liu X; Fan Y; Liu Y; He X; Zheng X; Tan J; Jia Q; Meng Z
    Updates Surg; 2020 Sep; 72(3):871-884. PubMed ID: 32342347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC/UICC Staging System Based on the SEER Database.
    Yang F; Zhong Q; Huang Z; Lian M; Fang J
    Front Endocrinol (Lausanne); 2019; 10():10. PubMed ID: 30733707
    [No Abstract]   [Full Text] [Related]  

  • 14. Using the American Thyroid Association Risk-Stratification System to Refine and Individualize the American Joint Committee on Cancer Eighth Edition Disease-Specific Survival Estimates in Differentiated Thyroid Cancer.
    Ghaznavi SA; Ganly I; Shaha AR; English C; Wills J; Tuttle RM
    Thyroid; 2018 Oct; 28(10):1293-1300. PubMed ID: 29897011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts.
    Pontius LN; Oyekunle TO; Thomas SM; Stang MT; Scheri RP; Roman SA; Sosa JA
    Thyroid; 2017 Nov; 27(11):1408-1416. PubMed ID: 28891405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of the BRAF-V600
    Gan X; Shen F; Deng X; Feng J; Lu J; Cai W; Peng L; Zheng W; Wang W; Huang P; Chen Z; Guo M; Xu B
    Oncol Lett; 2020 Jan; 19(1):631-640. PubMed ID: 31897179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Male sex is associated with aggressive behaviour and poor prognosis in Chinese papillary thyroid carcinoma.
    Ding J; Wu W; Fang J; Zhao J; Jiang L
    Sci Rep; 2020 Mar; 10(1):4141. PubMed ID: 32139703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age greater than 60 years portends a worse prognosis in patients with papillary thyroid cancer: should there be three age categories for staging?
    Kauffmann RM; Hamner JB; Ituarte PHG; Yim JH
    BMC Cancer; 2018 Mar; 18(1):316. PubMed ID: 29566662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
    Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
    BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The binary presence or absence of lymph node metastasis or extrathyroidal extension is not associated with survival in papillary thyroid cancers: Implications for staging systems.
    Zhang HS; Lee EK; Jung YS; Nam BH; Park B
    Cancer Epidemiol; 2019 Dec; 63():101589. PubMed ID: 31494519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.